Contrast echocardiography for assessment of left ventricular thrombi

Sahar S. Abdelmoneim, Patricia Pellikka, Sharon L. Mulvagh

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The diagnosis of intracardiac thrombi remains clinically relevant, with associated risks of systemic embolization and implications for antithrombotic management. Intravenously injected ultrasound contrast agents, composed of microbubbles smaller than red blood cells, have become established essential adjunctive tools for performance of state-of-the-art echocardiography, providing important information on cardiac structure and function. Despite advances in other imaging modalities, echocardiography remains the initial tool for diagnosis and risk stratification in patients predisposed to developing cardiac thrombi. Ultrasound contrast agents are approved for left ventricular (LV) opacification and endocardial border definition. Additionally, the use of contrast echocardiography facilitates LV thrombus detection by providing contrast opacification within the cardiac chambers to clearly show the "filling defect" of an intracardiac thrombus. Furthermore, contrast perfusion echocardiography can provide an assessment of the tissue characteristics of LV masses suspicious for intracardiac thrombi and, by differentiating an avascular thrombus from a tumor, results in improved diagnostic performance of echocardiography. This article presents a clinical vignette highlighting the sound judgment of using contrast echocardiography to aid in the diagnosis of LV thrombi and will review recent advances in imaging modalities for intracardiac thrombus detection.

Original languageEnglish (US)
Pages (from-to)1337-1344
Number of pages8
JournalJournal of Ultrasound in Medicine
Volume33
Issue number8
DOIs
StatePublished - Aug 1 2014

Fingerprint

Echocardiography
Thrombosis
Contrast Media
Microbubbles
Perfusion
Erythrocytes
Neoplasms

Keywords

  • Contrast echocardiography
  • Mass
  • Thrombus
  • Ultrasound education
  • Ultrasound microbubble contrast agents
  • Ventricular thrombus

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Contrast echocardiography for assessment of left ventricular thrombi. / Abdelmoneim, Sahar S.; Pellikka, Patricia; Mulvagh, Sharon L.

In: Journal of Ultrasound in Medicine, Vol. 33, No. 8, 01.08.2014, p. 1337-1344.

Research output: Contribution to journalArticle

Abdelmoneim, Sahar S. ; Pellikka, Patricia ; Mulvagh, Sharon L. / Contrast echocardiography for assessment of left ventricular thrombi. In: Journal of Ultrasound in Medicine. 2014 ; Vol. 33, No. 8. pp. 1337-1344.
@article{fbce8ed94bf94e8dbc4f9bcf4a4fc520,
title = "Contrast echocardiography for assessment of left ventricular thrombi",
abstract = "The diagnosis of intracardiac thrombi remains clinically relevant, with associated risks of systemic embolization and implications for antithrombotic management. Intravenously injected ultrasound contrast agents, composed of microbubbles smaller than red blood cells, have become established essential adjunctive tools for performance of state-of-the-art echocardiography, providing important information on cardiac structure and function. Despite advances in other imaging modalities, echocardiography remains the initial tool for diagnosis and risk stratification in patients predisposed to developing cardiac thrombi. Ultrasound contrast agents are approved for left ventricular (LV) opacification and endocardial border definition. Additionally, the use of contrast echocardiography facilitates LV thrombus detection by providing contrast opacification within the cardiac chambers to clearly show the {"}filling defect{"} of an intracardiac thrombus. Furthermore, contrast perfusion echocardiography can provide an assessment of the tissue characteristics of LV masses suspicious for intracardiac thrombi and, by differentiating an avascular thrombus from a tumor, results in improved diagnostic performance of echocardiography. This article presents a clinical vignette highlighting the sound judgment of using contrast echocardiography to aid in the diagnosis of LV thrombi and will review recent advances in imaging modalities for intracardiac thrombus detection.",
keywords = "Contrast echocardiography, Mass, Thrombus, Ultrasound education, Ultrasound microbubble contrast agents, Ventricular thrombus",
author = "Abdelmoneim, {Sahar S.} and Patricia Pellikka and Mulvagh, {Sharon L.}",
year = "2014",
month = "8",
day = "1",
doi = "10.7863/ultra.33.8.1337",
language = "English (US)",
volume = "33",
pages = "1337--1344",
journal = "Journal of Ultrasound in Medicine",
issn = "0278-4297",
publisher = "American Institute of Ultrasound in Medicine",
number = "8",

}

TY - JOUR

T1 - Contrast echocardiography for assessment of left ventricular thrombi

AU - Abdelmoneim, Sahar S.

AU - Pellikka, Patricia

AU - Mulvagh, Sharon L.

PY - 2014/8/1

Y1 - 2014/8/1

N2 - The diagnosis of intracardiac thrombi remains clinically relevant, with associated risks of systemic embolization and implications for antithrombotic management. Intravenously injected ultrasound contrast agents, composed of microbubbles smaller than red blood cells, have become established essential adjunctive tools for performance of state-of-the-art echocardiography, providing important information on cardiac structure and function. Despite advances in other imaging modalities, echocardiography remains the initial tool for diagnosis and risk stratification in patients predisposed to developing cardiac thrombi. Ultrasound contrast agents are approved for left ventricular (LV) opacification and endocardial border definition. Additionally, the use of contrast echocardiography facilitates LV thrombus detection by providing contrast opacification within the cardiac chambers to clearly show the "filling defect" of an intracardiac thrombus. Furthermore, contrast perfusion echocardiography can provide an assessment of the tissue characteristics of LV masses suspicious for intracardiac thrombi and, by differentiating an avascular thrombus from a tumor, results in improved diagnostic performance of echocardiography. This article presents a clinical vignette highlighting the sound judgment of using contrast echocardiography to aid in the diagnosis of LV thrombi and will review recent advances in imaging modalities for intracardiac thrombus detection.

AB - The diagnosis of intracardiac thrombi remains clinically relevant, with associated risks of systemic embolization and implications for antithrombotic management. Intravenously injected ultrasound contrast agents, composed of microbubbles smaller than red blood cells, have become established essential adjunctive tools for performance of state-of-the-art echocardiography, providing important information on cardiac structure and function. Despite advances in other imaging modalities, echocardiography remains the initial tool for diagnosis and risk stratification in patients predisposed to developing cardiac thrombi. Ultrasound contrast agents are approved for left ventricular (LV) opacification and endocardial border definition. Additionally, the use of contrast echocardiography facilitates LV thrombus detection by providing contrast opacification within the cardiac chambers to clearly show the "filling defect" of an intracardiac thrombus. Furthermore, contrast perfusion echocardiography can provide an assessment of the tissue characteristics of LV masses suspicious for intracardiac thrombi and, by differentiating an avascular thrombus from a tumor, results in improved diagnostic performance of echocardiography. This article presents a clinical vignette highlighting the sound judgment of using contrast echocardiography to aid in the diagnosis of LV thrombi and will review recent advances in imaging modalities for intracardiac thrombus detection.

KW - Contrast echocardiography

KW - Mass

KW - Thrombus

KW - Ultrasound education

KW - Ultrasound microbubble contrast agents

KW - Ventricular thrombus

UR - http://www.scopus.com/inward/record.url?scp=84905741344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905741344&partnerID=8YFLogxK

U2 - 10.7863/ultra.33.8.1337

DO - 10.7863/ultra.33.8.1337

M3 - Article

C2 - 25063398

AN - SCOPUS:84905741344

VL - 33

SP - 1337

EP - 1344

JO - Journal of Ultrasound in Medicine

JF - Journal of Ultrasound in Medicine

SN - 0278-4297

IS - 8

ER -